Compositions for treating Alzheimer's disease, associated dementia and epilepsy

摘要

Alzheimer's disease, related dementias and epilepsy are treated by administering in absence of an oily carrier or diluent which comprises at least one member of the group consisting of C8-18 saturated fatty acids, oleic acid and derivatives of these acids, to a person having the symptoms thereof, or to a person susceptible to epilepsy, a symptom-alleviating amount of a composition of matter which comprises (a) from about 13.0 to about 27.5% by weight of linolenic acid and/or derivatives thereof, and (b) about 87.0 to about 72.5% by weight of at least one compound selected from the group consisting of linoleic acid and/or derivatives thereof, the derivatives of linolenic and linoleic acid being calculated as the free acids, and being both physiologically hydrolyzable and pharmacologically acceptable, or of a pharmaceutical formulation or nutritional composition containing ingredients (a) and (b) in the recited proportions.